{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:34:47Z","timestamp":1762508087187,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000582","name":"Carnegie Trust Incentive Grant, Dunfermline, UK","doi-asserted-by":"publisher","award":["RIG007424"],"award-info":[{"award-number":["RIG007424"]}],"id":[{"id":"10.13039\/501100000582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.clon.2020.03.010","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T01:05:22Z","timestamp":1586567122000},"page":"e203-e208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Predicting Response to Radiotherapy in Cancer-Induced Bone Pain: Cytokines as a Potential Biomarker?"],"prefix":"10.1016","volume":"32","author":[{"given":"K.","family":"MacLeod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.J.A.","family":"Laird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.O.","family":"Carragher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Fallon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.A.","family":"Sande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2020.03.010_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(96)03267-8","article-title":"Malignant bone pain: pathophysiology and treatment","volume":"69","author":"Mercadante","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.clon.2020.03.010_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.clon.2011.03.003","article-title":"Mechanisms of cancer-induced bone pain","volume":"23","author":"Middlemiss","year":"2011","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2020.03.010_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.radonc.2018.01.003","article-title":"Update of the systematic review of palliative radiation therapy fractionation for bone metastases","volume":"126","author":"Rich","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2020.03.010_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijrobp.2008.10.044","article-title":"Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three Canadian cancer centers","volume":"75","author":"Hird","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2020.03.010_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-8140(99)00097-3","article-title":"8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up","volume":"52","author":"Yarnold","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2020.03.010_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.critrevonc.2018.10.008","article-title":"A\u00a0systematic review examining clinical markers and biomarkers of analgesic response to radiotherapy for cancer-induced bone pain","volume":"133","author":"Gardner","year":"2019","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.clon.2020.03.010_bib7","first-page":"96","article-title":"The unresolved role of systemic factors in bone metastasis","volume":"5","author":"Ubellacker","year":"2016","journal-title":"J\u00a0Bone Oncol"},{"key":"10.1016\/j.clon.2020.03.010_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.neuroscience.2010.04.022","article-title":"Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain","volume":"169","author":"Geis","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.clon.2020.03.010_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.lfs.2007.07.003","article-title":"Antihyperalgesic effects induced by the IL-1 receptor antagonist anakinra and increased IL-1beta levels in inflamed and osteosarcoma-bearing mice","volume":"81","author":"Baamonde","year":"2007","journal-title":"Life Sci"},{"issue":"Pt A","key":"10.1016\/j.clon.2020.03.010_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2013.08.003","article-title":"Cancer-induced bone pain: mechanisms and models","volume":"557","author":"Lozano-Ondoua","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.clon.2020.03.010_bib11","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.pain.2010.10.035","article-title":"Cancer pain and its relationship to systemic inflammation: an exploratory study","volume":"152","author":"Laird","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.clon.2020.03.010_bib12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1634\/theoncologist.2013-0120","article-title":"The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer","volume":"18","author":"Laird","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.clon.2020.03.010_bib13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2015.63.8221","article-title":"Randomized double-blind trial of pregabalin versus placebo in conjunction with palliative radiotherapy for cancer-induced bone pain","volume":"34","author":"Fallon","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2020.03.010_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.clon.2007.04.007","article-title":"Worst, average or current pain in the Brief Pain Inventory: which should be used to calculate the response to palliative radiotherapy in patients with bone metastases?","volume":"19","author":"Harris","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2020.03.010_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","article-title":"REporting recommendations for tumour MARKer prognostic studies (REMARK)","volume":"93","author":"McShane","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2020.03.010_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-8140(02)00170-6","article-title":"International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases","volume":"64","author":"Chow","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2020.03.010_bib17","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.ijrobp.2011.02.008","article-title":"Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases","volume":"82","author":"Chow","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2020.03.010_bib18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10549-011-1851-1","article-title":"Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer","volume":"133","author":"Panis","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clon.2020.03.010_bib19","doi-asserted-by":"crossref","first-page":"129034","DOI":"10.1155\/2015\/129034","article-title":"Cytokines as mediators of pain-related process in breast cancer","volume":"2015","author":"Panis","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.clon.2020.03.010_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.1780380202","article-title":"Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis","volume":"38","author":"Arend","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clon.2020.03.010_bib21","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jbmr.5650110802","article-title":"Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis","volume":"11","author":"Pacifici","year":"1996","journal-title":"J\u00a0Bone Mineral Res"},{"key":"10.1016\/j.clon.2020.03.010_bib22","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.neuroscience.2008.04.072","article-title":"Interleukin 1beta facilitates bone cancer pain in rats by enhancing NMDA receptor NR-1 subunit phosphorylation","volume":"154","author":"Zhang","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.clon.2020.03.010_bib23","doi-asserted-by":"crossref","first-page":"19973","DOI":"10.1074\/jbc.M113.454652","article-title":"CCN3 protein participates in bone regeneration as an inhibitory factor","volume":"288","author":"Matsushita","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clon.2020.03.010_bib24","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/s41419-018-1234-1","article-title":"CCN3 and DLL1 co-regulate osteogenic differentiation of mouse embryonic fibroblasts in a Hey1-dependent manner","volume":"9","author":"Su","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.clon.2020.03.010_bib25","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.ajpath.2011.01.033","article-title":"CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone","volume":"178","author":"Ouellet","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clon.2020.03.010_bib26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/carcin\/bgt103","article-title":"CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway","volume":"34","author":"Chen","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.clon.2020.03.010_bib27","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.2015.65.7742","article-title":"Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response","volume":"34","author":"Laird","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2020.03.010_bib28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.clon.2020.03.010_bib29","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1136\/bmj.314.7098.1843","article-title":"Oestrogen receptors and breast cancer","volume":"314","author":"Elledge","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.clon.2020.03.010_bib30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1200\/JCO.2010.33.1744","article-title":"American Society of Clinical Oncology statement: toward individualized care for patients with advanced cancer","volume":"29","author":"Peppercorn","year":"2011","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655520301497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655520301497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:47:54Z","timestamp":1760543274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655520301497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0936655520301497"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2020.03.010","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting Response to Radiotherapy in Cancer-Induced Bone Pain: Cytokines as a Potential Biomarker?","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2020.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}